NPPA reports 88% price reduction in one-third of domestic brands of medical devices following trade margin cap
NPPA has observed that these devices are important in managing Covid-19 pandemic, not only for home use, but in hospital management too. The National Pharmaceutical Pricing Authority (NPPA) has reported 88% price reduction in one-third of domestic brands of medical devices following trade margin cap at 70% for pulse oximeter, blood pressure monitoring machine, nebuliser, … Read more
